Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Double-blind, Randomised, Parallel Group Comparison of the Efficacy and Safety of Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Elective or Urgent Cardiac Surgery

NCT03574311 is registered in ClinicalTrials.gov with Turku University Hospital as lead sponsor.

NCT NCT03574311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03574311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Double-blind, Randomised, Parallel Group Comparison of the Efficacy and Safety of Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Elective or Urgent Cardiac Surgery
Lead sponsor
Turku University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
October 2, 2018
Completion date
December 31, 2023
Enrollment
210 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic aneurysm, thoracic, aortic valve stenosis, coronary artery disease, mitral valve disease, postoperative complications